---
search:
  boost: 2 
---

# Antibacterial and Antibacterial/Steroid Combinations

This is a subcategory of Otic Agents.

## Decision Tree

- [Antibacterial & Antibacterial Steroid Combinations - Ciprofloxacin, Ciprofloxacin/Dexamethasone*, Ciprofloxacin/Fluocinolone](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?origin=OfficeDotCom&lang=en-US&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBURjEzRU1XTk9DRkJSV1I2VUYxOEYzVDZBMiQlQCN0PWcu&topview=Preview){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                               | Generic Name | Quantity | Time (Days) |
| :-------------------------------------- | :----------- | :------: | :---------: |
| Cipro HC                                |              |          |             |
| Ciprodex <sup>BvG</sup>                 |              |          |             |
| Cortisporin-TC                          |              |          |             |
| Neomycin / Polymyxin B / Hydrocortisone |              |          |             |
| Ofloxacin                               |              |          |             |

### Non-Preferred

| Non-Preferred                 | Generic Name | Quantity | Time (Days) |
| :---------------------------- | :----------- | :------: | :---------: |
| Ciprofloxacin                 |              |          |             |
| Ciprofloxacin / Dexamethasone |              |          |             |
| Ciprofloxacin / Fluocinolone  |              |          |             |

## Authorizations

**Length of Authorizations**: 30 days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **7 days** with at least **one preferred** drug
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_Criteria%20_APPROVED.pdf#page=91){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_v7_Approved.pdf#page=30){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
